Javascript must be enabled to continue!
The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review
View through CrossRef
Apolipoprotein D is a chordate gene early originated in the Lipocalin protein family. Among other features, regulation of its expression in a wide variety of disease conditions in humans, as apparently unrelated as neurodegeneration or breast cancer, have called for attention on this gene. Also, its presence in different tissues, from blood to brain, and different subcellular locations, from HDL lipoparticles to the interior of lysosomes or the surface of extracellular vesicles, poses an interesting challenge in deciphering its physiological function: Is ApoD a moonlighting protein, serving different roles in different cellular compartments, tissues, or organisms? Or does it have a unique biochemical mechanism of action that accounts for such apparently diverse roles in different physiological situations? To answer these questions, we have performed a systematic review of all primary publications where ApoD properties have been investigated in chordates. We conclude that ApoD ligand binding in the Lipocalin pocket, combined with an antioxidant activity performed at the rim of the pocket are properties sufficient to explain ApoD association with different lipid-based structures, where its physiological function is better described as lipid-management than by long-range lipid-transport. Controlling the redox state of these lipid structures in particular subcellular locations or extracellular structures, ApoD is able to modulate an enormous array of apparently diverse processes in the organism, both in health and disease. The new picture emerging from these data should help to put the physiological role of ApoD in new contexts and to inspire well-focused future research.
Title: The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review
Description:
Apolipoprotein D is a chordate gene early originated in the Lipocalin protein family.
Among other features, regulation of its expression in a wide variety of disease conditions in humans, as apparently unrelated as neurodegeneration or breast cancer, have called for attention on this gene.
Also, its presence in different tissues, from blood to brain, and different subcellular locations, from HDL lipoparticles to the interior of lysosomes or the surface of extracellular vesicles, poses an interesting challenge in deciphering its physiological function: Is ApoD a moonlighting protein, serving different roles in different cellular compartments, tissues, or organisms? Or does it have a unique biochemical mechanism of action that accounts for such apparently diverse roles in different physiological situations? To answer these questions, we have performed a systematic review of all primary publications where ApoD properties have been investigated in chordates.
We conclude that ApoD ligand binding in the Lipocalin pocket, combined with an antioxidant activity performed at the rim of the pocket are properties sufficient to explain ApoD association with different lipid-based structures, where its physiological function is better described as lipid-management than by long-range lipid-transport.
Controlling the redox state of these lipid structures in particular subcellular locations or extracellular structures, ApoD is able to modulate an enormous array of apparently diverse processes in the organism, both in health and disease.
The new picture emerging from these data should help to put the physiological role of ApoD in new contexts and to inspire well-focused future research.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Abstract 1737: Lipocalin-2/NGAL expression is associated with poor prognostic variables in human mammary, endometrial and ovarian carcinomas
Abstract 1737: Lipocalin-2/NGAL expression is associated with poor prognostic variables in human mammary, endometrial and ovarian carcinomas
Abstract
BACKGROUND: Recent literature has shown that lipocalin-2, a lipophilic ligand transporter member of the lipocalin family has a possible role as a biomarker ...
Fel d 4, a cat lipocalin allergen
Fel d 4, a cat lipocalin allergen
SummaryBackground
Cat allergy is unique among allergy to mammals in that the major allergen Fel d 1 is a uteroglobin‐like protein and not a lipocalin. The biochemical spectru...
Lipocalin 2 could predict circulating MMP9 levels in patients with breast cancer
Lipocalin 2 could predict circulating MMP9 levels in patients with breast cancer
OBJECTIVES: Breast cancer is the most prevalent carcinoma found in Indonesian women, and its incidence remains high worldwide. Lipocalin 2 has been linked with the progression of b...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Genetic Variation Associated with Differences in the Response of Plasma Apolipoprotein B Levels to Dietary Fibre
Genetic Variation Associated with Differences in the Response of Plasma Apolipoprotein B Levels to Dietary Fibre
1. We hypothesized that differences within genes whose protein products are involved in apolipoprotein B metabolism could influence the response of plasma apolipoprotein B-containi...
Plasmalogen deficiency and the Alzheimer’s disease risk of apolipoprotein E4
Plasmalogen deficiency and the Alzheimer’s disease risk of apolipoprotein E4
Abstract
The ε4 allele of the APOE gene, encoding the E4 isoform of apolipoprotein E, is the leading genetic risk factor for late-onset Alzheimer’s disease. While...
The Value of Lipocalin-2 in Patients with Systemic Lupus Erythematosus.
The Value of Lipocalin-2 in Patients with Systemic Lupus Erythematosus.
Systemic lupus erythematosus (SLE) is a chronic autoimmune multisystem disease predominantly affecting women in the childbearing period. The majority of the pathology in SLE is rel...

